LIFEVANTAGE CORP Inventory
LIFEVANTAGE CORP (LFVN) had Inventory of $16.17 million as of 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-08-27
- 2026-06-30: Inventory, Net $16.17M.
- 2026-03-31: Inventory, Net $18.38M.
- 2025-12-31: Inventory, Net $18.98M.
- 2025-09-30: Inventory, Net $20.59M.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2026-06-30 | $16.17M 10-K · filed 2026-08-27 | |
| 2026-03-31 | $18.38M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $18.98M 10-Q · filed 2026-02-04 | |
| 2025-09-30 | $20.59M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $20.67M 10-K · filed 2026-08-27 | |
| 2025-03-31 | $22.22M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $17.47M 10-Q · filed 2025-02-05 | |
| 2024-09-30 | $16.91M 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $15.05M 10-K · filed 2025-09-04 | |
| 2024-03-31 | $15.16M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $14.97M 10-Q · filed 2024-01-30 | |
| 2023-09-30 | $15.71M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $16.07M 10-K · filed 2024-08-28 | |
| 2023-03-31 | $18.45M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $20.43M 10-Q · filed 2023-02-02 | |
| 2022-09-30 | $18.64M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $16.47M 10-K · filed 2023-08-28 | |
| 2022-03-31 | $16.28M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $15.43M 10-Q · filed 2022-02-01 | |
| 2021-09-30 | $16.08M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $16.14M 10-K · filed 2022-08-23 | |
| 2021-03-31 | $14.82M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $14.71M 10-Q · filed 2021-02-02 | |
| 2020-09-30 | $14.80M 10-Q · filed 2020-11-03 | |
| 2020-06-30 | $13.89M 10-K · filed 2021-08-19 | |
| 2020-03-31 | $14.74M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $14.22M 10-Q · filed 2020-01-28 | |
| 2019-09-30 | $14.78M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $13.75M 10-K · filed 2020-08-18 | |
| 2019-03-31 | $14.49M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $13.30M 10-Q · filed 2019-02-04 | |
| 2018-09-30 | $13.28M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $13.63M 10-K · filed 2019-08-14 | |
| 2018-03-31 | $15.82M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $16.82M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $15.36M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $16.57M 10-K · filed 2018-08-15 | |
| 2017-03-31 | $19.14M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $21.38M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $23.92M 10-Q · filed 2016-12-12 | |
| 2016-06-30 | $25.12M 10-K · filed 2017-09-07 | |
| 2016-03-31 | $17.00M 10-Q/A · filed 2016-07-19 | |
| 2015-12-31 | $10.62M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $8.54M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $9.25M 10-K · filed 2016-12-12 | |
| 2015-03-31 | $10.90M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $12.10M 10-Q · filed 2015-02-04 | |
| 2014-09-30 | $11.01M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $8.83M 10-K · filed 2015-09-01 | |
| 2014-03-31 | $8.58M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $9.84M 10-Q · filed 2014-02-06 | |
| 2013-09-30 | $10.63M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $10.52M 10-K · filed 2014-09-10 | |
| 2013-03-31 | $8.03M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $9.55M 10-Q · filed 2013-02-07 | |
| 2012-09-30 | $13.07M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $11.35M 10-K · filed 2013-09-12 | $11.35M 10-K · filed 2012-09-10 |
| 2012-03-31 | $6.98M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $3.03M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $2.76M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $2.12M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |